FindTrial
Sign In

Retrospective analysis of the analgesic effect of sufentanil combined with dexmedetomidine and flurbiprofen for postoperative gastrointestinal surgery

Retrospective analysis of the analgesic effect of sufentanil combined with dexmedetomidine and flurbiprofen for postoperative gastrointestinal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021297
Enrollment
Unknown
Registered
2019-02-12
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal tumor

Interventions

Case Series:Sufentanil combined with dexmedetomidine and flurbiprofen was used for postoperative analgesia after gastrointestinal surgery

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged at least 18 years; 2. Open gastrointestinal surgery; 3. ASA level I-III; 4. Postoperative treatment with sufentanil combined with dexmedetomidine and flurbiprofen ester for controlled intravenous analgesia.

Exclusion criteria

Exclusion criteria: 1. Patients with severe drug allergy; 2. Coronary heart disease, coronary heart disease stent placement, severe heart failure, severe liver and kidney and blood system dysfunction; 3. Weight = 40kg; 4. Postoperative follow-up data incomplete.

Design outcomes

Primary

MeasureTime frame
VAS pain score and activity pain score at 24h/48h postoperatively;—

Secondary

MeasureTime frame
Incidence of nausea and vomiting;—

Countries

China

Contacts

Public ContactYin Lu

West China Hospital of Sichuan University

1126700947@qq.com+86 13739469477

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026